Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2017 (2017), Article ID 4702067, 9 pages
https://doi.org/10.1155/2017/4702067
Research Article

Glucose-Insulin-Potassium Alleviates Intestinal Mucosal Barrier Injuries Involving Decreased Expression of Uncoupling Protein 2 and NLR Family-Pyrin Domain-Containing 3 Inflammasome in Polymicrobial Sepsis

1Center of Pediatrics, Zhujiang Hospital, Southern Medical University, Guangzhou, Guangdong 510280, China
2Department of Neonatology, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong 510515, China
3Clinical Laboratory Center, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong 510515, China
4Department of Pediatrics, Central Hospital of Panyu District, Guangzhou, Guangdong 511486, China

Correspondence should be addressed to Qi-yi Zeng

Received 6 December 2016; Accepted 5 February 2017; Published 27 March 2017

Academic Editor: James D. Murray

Copyright © 2017 Jun-liang Zhang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. E. Abraham, “New definitions for sepsis and septic shock continuing evolution but with much still to be done,” JAMA, vol. 315, no. 8, pp. 757–759, 2016. View at Publisher · View at Google Scholar · View at Scopus
  2. J. Stoller, L. Halpin, M. Weis et al., “Epidemiology of severe sepsis: 2008-2012,” Journal of Critical Care, vol. 31, no. 1, pp. 58–62, 2016. View at Publisher · View at Google Scholar · View at Scopus
  3. D. A. Anaya and A. B. Nathens, “Risk factors for severe sepsis in secondary peritonitis,” Surgical Infections, vol. 4, no. 4, pp. 355–362, 2003. View at Publisher · View at Google Scholar · View at Scopus
  4. N. J. Klingensmith and C. M. Coopersmith, “The gut as the motor of multiple organ dysfunction in critical illness,” Critical Care Clinics, vol. 32, no. 2, pp. 203–212, 2016. View at Publisher · View at Google Scholar · View at Scopus
  5. L. Qi, Q. Fu, C. Du et al., “Amelioration of hypoxia and LPS-induced intestinal epithelial barrier dysfunction by emodin through the suppression of the NF-κB and HIF-1α signaling pathways,” International Journal of Molecular Medicine, vol. 34, no. 6, pp. 1629–1639, 2014. View at Publisher · View at Google Scholar · View at Scopus
  6. J. R. Turner, “Intestinal mucosal barrier function in health and disease,” Nature Reviews Immunology, vol. 9, no. 11, pp. 799–809, 2009. View at Publisher · View at Google Scholar · View at Scopus
  7. M. Utech, M. Brüwer, and A. Nusrat, “Tight junctions and cell-cell interactions,” Methods in Molecular Biology, vol. 341, pp. 185–195, 2006. View at Google Scholar · View at Scopus
  8. J. A. Clark and C. M. Coopersmith, “Intestinal crosstalk: a new paradigm for understanding the gut as the ‘motor’ of critical illness,” Shock, vol. 28, no. 4, pp. 384–393, 2007. View at Publisher · View at Google Scholar · View at Scopus
  9. S. Straus, V. Gerc, M. Kacila, and C. Faruk, “Glucosa-Insulin-Potassium (GIK) solution used with diabetic patients provides better recovery after coronary bypass operations,” Medical Archives, vol. 67, no. 2, pp. 84–87, 2013. View at Publisher · View at Google Scholar · View at Scopus
  10. L. R. Filgueiras, V. L. Capelozzi, J. O. Martins, and S. Jancar, “Sepsis-induced lung inflammation is modulated by insulin,” BMC Pulmonary Medicine, vol. 14, article 177, 2014. View at Publisher · View at Google Scholar · View at Scopus
  11. H. Tuzcu, I. Aslan, and M. Aslan, “The effect of high-dose insulin analog initiation therapy on lipid peroxidation products and oxidative stress markers in type 2 diabetic patients,” Oxidative Medicine and Cellular Longevity, vol. 2013, Article ID 513742, 9 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  12. L. Guan, D. Gong, N. Tian, and Y. Zou, “Uncoupling protein 2 involved in protection of glucagon-like peptide 2 in small intestine with ischemia-reperfusion injury in mice,” Digestive Diseases and Sciences, vol. 50, no. 3, pp. 554–560, 2005. View at Publisher · View at Google Scholar · View at Scopus
  13. I. Shabalina, C. Wiklund, T. Bengtsson, A. Jacobsson, B. Cannon, and J. Nedergaard, “Uncoupling protein-1: involvement in a novel pathway for β-adrenergic, cAMP-mediated intestinal relaxation,” American Journal of Physiology—Gastrointestinal and Liver Physiology, vol. 283, no. 5, pp. G1107–G1116, 2002. View at Publisher · View at Google Scholar · View at Scopus
  14. H. Zhang, X.-Y. Kuai, P. Yu, L. Lin, and R. Shi, “Protective role of uncoupling protein-2 against dextran sodium sulfate-induced colitis,” Journal of Gastroenterology and Hepatology, vol. 27, no. 3, pp. 603–608, 2012. View at Publisher · View at Google Scholar · View at Scopus
  15. K. S. Echtay, M. Bienengraeber, E. Winkler, and M. Klingenberg, “In the uncoupling protein (UCP-1) His-214 is involved in the regulation of purine nucleoside triphosphate but not diphosphate binding,” Journal of Biological Chemistry, vol. 273, no. 38, pp. 24368–24374, 1998. View at Publisher · View at Google Scholar · View at Scopus
  16. S. Deng, Y. Yang, Y. Han et al., “UCP2 inhibits ROS-mediated apoptosis in A549 under hypoxic conditions,” PLoS ONE, vol. 7, no. 1, Article ID e30714, 2012. View at Publisher · View at Google Scholar · View at Scopus
  17. S. Diano and T. L. Horvath, “Mitochondrial uncoupling protein 2 (UCP2) in glucose and lipid metabolism,” Trends in Molecular Medicine, vol. 18, no. 1, pp. 52–58, 2012. View at Publisher · View at Google Scholar · View at Scopus
  18. V. Rajanbabu, L. Galam, J. Fukumoto et al., “Genipin suppresses NLRP3 inflammasome activation through uncoupling protein-2,” Cellular Immunology, vol. 297, no. 1, pp. 40–45, 2015. View at Publisher · View at Google Scholar · View at Scopus
  19. J.-S. Moon, S. Lee, M.-A. Park et al., “UCP2-induced fatty acid synthase promotes NLRP3 inflammasome activation during sepsis,” Journal of Clinical Investigation, vol. 125, no. 2, pp. 665–680, 2015. View at Publisher · View at Google Scholar · View at Scopus
  20. D. Rittirsch, M. S. Huber-Lang, M. A. Flierl, and P. A. Ward, “Immunodesign of experimental sepsis by cecal ligation and puncture,” Nature Protocols, vol. 4, no. 1, pp. 31–36, 2009. View at Publisher · View at Google Scholar · View at Scopus
  21. C.-J. Chiu, A. H. McArdle, R. Brown, H. J. Scott, and F. N. Gurd, “Intestinal mucosal lesion in low-flow states: I. A morphological, hemodynamic, and metabolic reappraisal,” Archives of Surgery, vol. 101, no. 4, pp. 478–483, 1970. View at Publisher · View at Google Scholar · View at Scopus
  22. B. P. Yoseph, N. J. Klingensmith, Z. Liang et al., “Mechanisms of intestinal barrier dysfunction in sepsis,” Shock, vol. 46, no. 1, pp. 52–59, 2016. View at Publisher · View at Google Scholar · View at Scopus
  23. S. Finfer and F. R. Machado, “The global epidemiology of sepsis. does it matter that we know so little?” American Journal of Respiratory and Critical Care Medicine, vol. 193, no. 3, pp. 228–230, 2016. View at Publisher · View at Google Scholar · View at Scopus
  24. J. Suliburk, K. Helmer, F. Moore, and D. Mercer, “The gut in systemic inflammatory response syndrome and sepsis: enzyme systems fighting multiple organ failure,” European Surgical Research, vol. 40, no. 2, pp. 184–189, 2008. View at Publisher · View at Google Scholar · View at Scopus
  25. L. E. Fredenburgh, M. M. S. Velandia, J. Ma et al., “Cyclooxygenase-2 deficiency leads to intestinal barrier dysfunction and increased mortality during polymicrobial sepsis,” Journal of Immunology, vol. 187, no. 10, pp. 5255–5267, 2011. View at Publisher · View at Google Scholar · View at Scopus
  26. H. P. Selker, J. E. Udelson, J. M. Massaro et al., “One-year outcomes of out-of-hospital administration of intravenous glucose, insulin, and potassium (GIK) in patients with suspected acute coronary syndromes (from the IMMEDIATE [Immediate Myocardial Metabolic Enhancement during Initial Assessment and Treatment in Emergency Care] Trial),” American Journal of Cardiology, vol. 113, no. 10, pp. 1599–1605, 2014. View at Publisher · View at Google Scholar · View at Scopus
  27. S. Di Marco, B. Boldrini, U. Conti et al., “Effects of GIK (glucose-insulin-potassium) on stress-induced myocardial ischaemia,” Clinical Science, vol. 119, no. 1, pp. 37–44, 2010. View at Publisher · View at Google Scholar · View at Scopus
  28. Z. Wang, L. Liu, T. Hu et al., “Protective effect of glucose-insulin-potassium (GIK) on intestinal tissues after severe burn in experimental rats,” Burns, vol. 38, no. 6, pp. 846–854, 2012. View at Publisher · View at Google Scholar · View at Scopus
  29. K. L. Ellis, Y. Zhou, J. R. Beshansky et al., “Genetic variation at glucose and insulin trait loci and response to glucose-insulin-potassium (GIK) therapy: the IMMEDIATE trial,” Pharmacogenomics Journal, vol. 15, no. 1, pp. 55–62, 2015. View at Publisher · View at Google Scholar · View at Scopus
  30. M. Tohno, T. Shimosato, H. Aso, and H. Kitazawa, “Immunobiotic Lactobacillus strains augment NLRP3 expression in newborn and adult porcine gut-associated lymphoid tissues,” Veterinary Immunology and Immunopathology, vol. 144, no. 3-4, pp. 410–416, 2011. View at Publisher · View at Google Scholar · View at Scopus
  31. C. Toda and S. Diano, “Mitochondrial UCP2 in the central regulation of metabolism,” Best Practice and Research: Clinical Endocrinology and Metabolism, vol. 28, no. 5, pp. 757–764, 2014. View at Publisher · View at Google Scholar · View at Scopus
  32. L. Qi, X. Cui, W. Dong et al., “Ghrelin protects rats against traumatic brain injury and hemorrhagic shock through upregulation of UCP2,” Annals of Surgery, vol. 260, no. 1, pp. 169–178, 2014. View at Publisher · View at Google Scholar · View at Scopus
  33. G. Zheng, J. Lyu, S. Liu et al., “Silencing of uncoupling protein 2 by small interfering RNA aggravates mitochondrial dysfunction in cardiomyocytes under septic conditions,” International Journal of Molecular Medicine, vol. 35, no. 6, pp. 1525–1536, 2015. View at Publisher · View at Google Scholar · View at Scopus
  34. Q. Wang, J. Wang, M. Hu et al., “Uncoupling protein 2 increases susceptibility to lipopolysaccharide-induced acute lung injury in mice,” Mediators of Inflammation, vol. 2016, Article ID 9154230, 13 pages, 2016. View at Publisher · View at Google Scholar · View at Scopus
  35. R. E. Abdelhamid, K. J. Kovács, M. G. Nunez, and A. A. Larson, “After a cold conditioning swim, UCP2-deficient mice are more able to defend against the cold than wild type mice,” Physiology and Behavior, vol. 135, pp. 168–173, 2014. View at Publisher · View at Google Scholar · View at Scopus
  36. M. Donadelli, I. Dando, C. Fiorini, and M. Palmieri, “UCP2, a mitochondrial protein regulated at multiple levels,” Cellular and molecular life sciences : CMLS, vol. 71, no. 7, pp. 1171–1190, 2014. View at Publisher · View at Google Scholar · View at Scopus
  37. E. M. Allister, C. A. Robson-Doucette, K. J. Prentice et al., “UCP2 regulates the glucagon response to fasting and starvation,” Diabetes, vol. 62, no. 5, pp. 1623–1633, 2013. View at Publisher · View at Google Scholar · View at Scopus
  38. Y. Zhong, C. Teixeira, N. Marungruang et al., “Barley malt increases hindgut and portal butyric acid, modulates gene expression of gut tight junction proteins and Toll-like receptors in rats fed high-fat diets, but high advanced glycation end-products partially attenuate the effects,” Food and Function, vol. 6, no. 9, pp. 3165–3176, 2015. View at Publisher · View at Google Scholar · View at Scopus